A bill for an act relating to cost-sharing requirements for supplemental and diagnostic breast examinations.
If enacted, SSB1060 will directly affect how third-party payment provider contracts are structured in the state of Iowa. By removing cost-sharing for supplemental and diagnostic breast examinations, the bill is expected to increase access to crucial health services. This can potentially lead to earlier detection and better outcomes for breast cancer and other breast-related health issues, ultimately benefiting public health in the state.
Senate Study Bill 1060 aims to address the cost-sharing requirements associated with supplemental and diagnostic breast examinations for covered persons under health insurance policies. Specifically, the bill prohibits health plans from imposing any out-of-pocket costs, such as copayments or deductibles, on these medically necessary examinations. This initiative is part of a broader effort to ensure that insured individuals have access to necessary diagnostic care without incurring additional financial burdens.
However, there are potential points of contention surrounding the bill. Critics of similar health care measures often argue that eliminating cost-sharing could lead to increased insurance premiums as providers adjust their pricing models to account for these mandated coverage expansions. Additionally, concerns may arise regarding the financial implications for insurance companies and the sustainability of such provisions in the long term.
The provisions of this bill are set to apply to all contracts, policies, and plans issued or renewed on or after January 1, 2026. This delayed implementation allows time for insurance providers to adjust their policies in accordance with the new regulations.